Video
ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
HSCT: Donor selection for patients with ALL
Prof Sebastian Giebel - The Maria Skłodowska-Curie Institute of Oncology, Gliwic...
23 Jan 2020
Long-term toxicities in paediatric ALL
Prof Kjeld Schmiegelow - University of Copenhagen, Copenhagen, Denmark
23 Jan 2020
How is minimal residual disease managed in patients with ALL?
Dr Renato Bassan - Ospedale dell'Angelo & Ospedale SS, Venice, Italy
23 Jan 2020
Frontline therapy of ALL
Prof Hervé Dombret - University Paris Diderot, Paris, France
23 Jan 2020
BiTE therapy followed by HSCT vs CAR-T cells in young patients with R/R ALL
Prof Hervé Dombret - University Paris Diderot, Paris, France
23 Jan 2020
The new era of ALL treatment
Dr Josep Ribera - Catalan Institute of Oncology, Barcelona, Spain
23 Jan 2020
Oral paclitaxel yields better outcomes than IV paclitaxel in metastatic breast c...
Dr Gerardo Umanzor - Hospital del Valle, San Pedro Sula, Honduras
23 Jan 2020
Novel therapeutic approaches in B-progenitor ALL
Dr Charles Mullighan - St. Jude's Children's Research Hospital, Memphis, USA
23 Jan 2020
Identifying cancer susceptibility genes in paediatric ALL
Dr Ching-Hon Pui - St Jude's Children's Research Hospital, Memphis, USA
23 Jan 2020
Defining high-risk acute lymphoblastic leukaemia
Dr Ching-Hon Pui - St Jude's Children's Research Hospital, Memphis, USA
23 Jan 2020
Safe staffing and patient outcomes
Prof Anne Marie Rafferty - King's College London, London, UK
13 Jan 2020
Discussing the treatment of head and neck tumours in India
Dr Prateek Jain - Tata Medical Center, Kolkata, India
10 Jan 2020
